Junyan Gao, Yixin Hu, Li Gao, Peifang Xiao, Jun Lu, & Shaoyan Hu. (2022). The effect of decitabine-combined minimally myelosuppressive regimen bridged allo-HSCT on the outcomes of pediatric MDS from 10 years' experience of a single center. BMC.
Chicago Style (17th ed.) CitationJunyan Gao, Yixin Hu, Li Gao, Peifang Xiao, Jun Lu, and Shaoyan Hu. The Effect of Decitabine-combined Minimally Myelosuppressive Regimen Bridged Allo-HSCT on the Outcomes of Pediatric MDS from 10 years' Experience of a Single Center. BMC, 2022.
MLA (9th ed.) CitationJunyan Gao, et al. The Effect of Decitabine-combined Minimally Myelosuppressive Regimen Bridged Allo-HSCT on the Outcomes of Pediatric MDS from 10 years' Experience of a Single Center. BMC, 2022.
Warning: These citations may not always be 100% accurate.